Vertex Pharmaceuticals (Q20437): Difference between revisions
Jump to navigation
Jump to search
Created claim: described at URL (P408): https://beststocks.com/institutional-investors-show-interest-in-biotech-c/ |
Created claim: described at URL (P408): https://www.businesswire.com/news/home/20230623446641/en/Vertex-Presents-Positive-VX-880-Results-From-Ongoing-Phase-12-Study-in-Type-1-Diabetes-at-the-American-Diabetes-Association-83rd-Scientific-Sessions |
||
Property / described at URL | |||
Property / described at URL: https://www.businesswire.com/news/home/20230623446641/en/Vertex-Presents-Positive-VX-880-Results-From-Ongoing-Phase-12-Study-in-Type-1-Diabetes-at-the-American-Diabetes-Association-83rd-Scientific-Sessions / rank | |||
Normal rank | |||
Property / described at URL: https://www.businesswire.com/news/home/20230623446641/en/Vertex-Presents-Positive-VX-880-Results-From-Ongoing-Phase-12-Study-in-Type-1-Diabetes-at-the-American-Diabetes-Association-83rd-Scientific-Sessions / qualifier | |||
Revision as of 20:03, 16 January 2024
American pharmaceutical company
- Vertex Pharmaceuticals Inc.
- Vertex
Language | Label | Description | Also known as |
---|---|---|---|
English | Vertex Pharmaceuticals |
American pharmaceutical company |
|
Statements
1989
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references